AMN Healthcare Services (AMN) FY2017 results: revenue $2.0 billion, up 4.5% on the year
AMN Healthcare Services Inc. (AMN) reported revenue of $2.0 billion for fiscal 2017, the year ended 31 December 2017, up 4.5% on the year before. Net income was $133 million, up 25.2%, and diluted earnings per share $2.68. The figures are the company's own, from the 10-K it filed with the SEC on 16 February 2018.
Revenue
$2.0 billion
+4.5% on the year
FY2010FY2017
Operating margin
10.7%
10.1% a year earlier
FY2010FY2017
Net income
$133 million
+25.2% on the year
FY2010FY2017
Diluted EPS
$2.68
+24.7% on the year
FY2010FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
1,988
1,902
1,463
+4.5%
Cost of revenue
1,344
1,283
994
+4.8%
Gross profit
644
620
469
+4.0%
Gross margin
32.4%
32.6%
32.1%
Selling, general and administrative
400
398
320
+0.3%
Operating income
212
192
129
+10.9%
Operating margin
10.7%
10.1%
8.8%
Interest expense
19.7
15.5
7.8
+27.2%
Pre-tax income
193
176
121
+9.4%
Income tax
60.2
70.3
39.2
-14.4%
Effective tax rate
31.2%
39.9%
32.4%
Net income
133
106
81.9
+25.2%
Net margin
6.7%
5.6%
5.6%
Diluted EPS
$2.68
$2.15
$1.68
+24.7%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
161
134
56.3
+19.9%
Capital expenditure
26.5
22.0
27.0
+20.8%
Free cash flow
134
112
29.3
+19.7%
Free cash flow margin
6.7%
5.9%
2.0%
Cash from investing
-35.4
-258
-116
Cash from financing
-77.2
126
56.2
Depreciation and amortisation
32.3
29.6
21.0
+9.0%
Share-based compensation
10.2
11.4
10.3
-10.2%
Buybacks
20.2
13.3
0.0
+52.1%
Diluted shares, weighted
49m
49m
49m
+0.3%
Shares outstanding at period end
47m
48m
48m
-0.3%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
563
449
348
+25.2%
Debt
320
363
218
-11.9%
Other liabilities
372
375
314
-0.8%
Total liabilities and equity
1,254
1,187
880
+5.7%
Fixed assets
73.4
60.0
50.1
+22.5%
Goodwill
341
342
205
-0.3%
Intangible assets
227
246
175
-7.6%
Cash and equivalents
15.1
10.6
9.6
+42.6%
Receivables
350
342
278
+2.5%
Other assets
247
187
163
+32.3%
Total assets
1,254
1,187
880
+5.7%
10-K for the year ended 31 December 2017, filed 16 February 2018: the filing.